Metformin-Related Agents May Suppress HIV Latent Reservoirs (scitechdaily.com)

• Identified drug class effectively targets dormant HIV-1 infection.
• Mechanism involves modulating T-cell energy metabolism to prevent viral rebound.
• Potential reduction in chronic inflammatory markers associated with long-term ART.

"A common metabolic drug has demonstrated the ability to inhibit the reactivation of latent HIV reservoirs in human immune cells. This finding suggests a novel pathway for managing HIV persistence by altering the metabolic environment required for the virus to replicate once antiretroviral therapy is interrupted. This approach could reduce the necessity for lifelong continuous medication, potentially achieving long-term remission through metabolic modulation."